Humana Inc. (HUM)

Check out top investors' recommendation for HUM
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
270.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Humana Inc., a health care company, offers insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Health and Well-Being Services. Its Retail segment provides Medicare and commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products to individuals. The company’s Employer Group segment offers Medicare and commercial fully insured medical and specialty health insurance benefits, as well as administrative services to employer groups. Its Health and Well-Being Services segment provides pharmacy, provider services, integrated wellness, and home care services enrolled in its health plan, as well as to third parties that promote health and wellness. The company’s other businesses category consists of military services, primarily its TRICARE south region contract that provides health insurance coverage to the dependents of active duty and retired military personnel and their dependents; Medicaid, a federal program to facilitate the delivery of health care services primarily to low-income residents; and closed-block long-term care businesses, as well as contract with Centers for Medicare and Medicaid Services (CMS) to administer the LI-NET (Limited Income Newly Eligible Transition) program, which allows individuals to receive immediate prescription drug coverage. As of December 31, 2012, Humana Inc. had approximately 12.1 million members enrolled in medical benefit plans; and approximately 8.1 million members enrolled in specialty products programs. Humana Inc. was formerly known as Extendicare Inc. and changed its name in April 1974. The company was founded in 1961 and is headquartered in Louisville, Kentucky.
Sector:
Industry:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
David Windley Jefferies & Co. Buy   Jan 12, '18       Jan 12, '19  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Dec 19, '17     255.00  Dec 19, '18  N/A 
Christine Arnold Cowen And Company Buy   Dec 13, '17     285.00  Dec 13, '18  N/A 
Ana Gupte Dowling & Partners Securities, LLC Buy   Nov 27, '17     280.00  Nov 27, '18  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Nov 08, '17     255.00  Nov 08, '18  N/A 
Christine Arnold Cowen And Company Buy   Oct 23, '17     275.00  Oct 23, '18  N/A 
Christine Arnold Cowen And Company Buy   Sep 20, '17     275.00  Sep 20, '18  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Aug 02, '17     236.00  Aug 02, '18  N/A 
Kevin Fischbeck BofA Merrill Lynch Buy   Jul 14, '17     275.00  Jul 14, '18  N/A 
Scott Fidel Deutsche Bank Securities Buy   Jul 13, '17     250.00  Jul 13, '18  N/A 
Sarah James Wedbush Securities Inc. Buy   Jul 13, '17     246.00  Jul 13, '18  N/A 
Christine Arnold Cowen And Company Buy   Jul 13, '17     230.00  Jul 13, '18  N/A 
Ralph Giacobbe Credit Suisse Buy   Jun 28, '17     275.00  Jun 28, '18  N/A 
Christine Arnold Cowen And Company Buy   Apr 25, '17     230.00  Apr 25, '18  N/A 
Kevin Fischbeck BofA Merrill Lynch Buy   Jan 27, '17     250.00  Jan 27, '18  N/A 
Ana Gupte Dowling & Partners Securities, LLC Buy   Jan 23, '17     250.00  Jan 23, '18  N/A 
David Windley Jefferies & Co. Buy   Dec 01, '16     230.00  Dec 01, '17  N/A 
David Windley Jefferies & Co. Buy   Jul 18, '16       Jul 18, '17  N/A 
Gerardo Torculas Unaffiliated Buy   Jul 17, '16   159.64  170.00  Aug 17, '16  12.52% 
Thomas Carroll Stifel Nicolaus & Company, Inc. Buy   May 05, '16     220.00  May 05, '17  N/A 
< previous12345